164 related articles for article (PubMed ID: 15478042)
21. Familial combined hyperlipidemia: upstream transcription factor 1 and beyond.
Lee JC; Lusis AJ; Pajukanta P
Curr Opin Lipidol; 2006 Apr; 17(2):101-9. PubMed ID: 16531745
[TBL] [Abstract][Full Text] [Related]
22. Assessment of reaching goal in patients with combined hyperlipidemia: low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, or apolipoprotein B.
Stein EA; Sniderman A; Laskarzewski P
Am J Cardiol; 2005 Nov; 96(9A):36K-43K; discussion 34K-35K. PubMed ID: 16291013
[TBL] [Abstract][Full Text] [Related]
23. Plasma triglycerides and type III hyperlipidemia are independently associated with premature familial coronary artery disease.
Hopkins PN; Wu LL; Hunt SC; Brinton EA
J Am Coll Cardiol; 2005 Apr; 45(7):1003-12. PubMed ID: 15808755
[TBL] [Abstract][Full Text] [Related]
24. FAMILIAL COMBINED HYPERLIPIDEMIA: CURRENT KNOWLEDGE, PERSPECTIVES, AND CONTROVERSIES.
Bello-Chavolla OY; Kuri-García A; Ríos-Ríos M; Vargas-Vázquez A; Cortés-Arroyo JE; Tapia-González G; Cruz-Bautista I; Aguilar-Salinas CA
Rev Invest Clin; 2018; 70(5):224-236. PubMed ID: 30307446
[TBL] [Abstract][Full Text] [Related]
25. [Familial combined hyperlipidemia - the most common genetic dyslipidemia in population and in patients with premature atherothrombotic cardiovascular disease].
Vaverková H; Karásek D
Vnitr Lek; 2018; 64(1):25-29. PubMed ID: 29498872
[TBL] [Abstract][Full Text] [Related]
26. Correlation of non-high-density lipoprotein cholesterol and low-density lipoprotein cholesterol with apolipoprotein B during simvastatin + fenofibrate therapy in patients with combined hyperlipidemia (a subanalysis of the SAFARI trial).
Grundy SM; Vega GL; Tomassini JE; Tershakovec AM
Am J Cardiol; 2009 Aug; 104(4):548-53. PubMed ID: 19660610
[TBL] [Abstract][Full Text] [Related]
27. [Familial combined hyperlipidemia].
de Bruin TW; Dallinga-Thie GM; Erkelens DW
Ned Tijdschr Geneeskd; 1996 Oct; 140(43):2118-21. PubMed ID: 8965962
[No Abstract] [Full Text] [Related]
28. High frequency of a retinoid X receptor gamma gene variant in familial combined hyperlipidemia that associates with atherogenic dyslipidemia.
Nohara A; Kawashiri MA; Claudel T; Mizuno M; Tsuchida M; Takata M; Katsuda S; Miwa K; Inazu A; Kuipers F; Kobayashi J; Koizumi J; Yamagishi M; Mabuchi H
Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):923-8. PubMed ID: 17272748
[TBL] [Abstract][Full Text] [Related]
29. Phenotype expression in familial combined hyperlipidemia.
Porkka KV; Nuotio I; Pajukanta P; Ehnholm C; Suurinkeroinen L; Syvänne M; Lehtimäki T; Lahdenkari AT; Lahdenperä S; Ylitalo K; Antikainen M; Perola M; Raitakari OT; Kovanen P; Viikari JS; Peltonen L; Taskinen MR
Atherosclerosis; 1997 Sep; 133(2):245-53. PubMed ID: 9298685
[TBL] [Abstract][Full Text] [Related]
30. [Familial combined hyperlipidemia; solution on the horizon?].
Porkka K; Taskinen MR
Duodecim; 1995; 111(18):1755-62. PubMed ID: 9340268
[No Abstract] [Full Text] [Related]
31. [Familial combined hyperlipidemia].
Takagi A; Ikeda Y
Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):76-9. PubMed ID: 9645012
[No Abstract] [Full Text] [Related]
32. Association between physical activity, adiposity, and lipid abnormalities in children with familial hyperlipidemia.
Thavendiranathan P; Jones E; Han RK; Cullen-Dean G; Helden E; Conner WT; McCrindle BW
Eur J Cardiovasc Prev Rehabil; 2007 Feb; 14(1):59-64. PubMed ID: 17301628
[TBL] [Abstract][Full Text] [Related]
33. [New lipid factors of cardiovascular risk].
Bruckert E; Turpin G
Ann Cardiol Angeiol (Paris); 1994 Oct; 43(8):458-60. PubMed ID: 7825948
[TBL] [Abstract][Full Text] [Related]
34. Familial-combined hyperlipidaemia in very young myocardial infarction survivors (< or =40 years of age).
Wiesbauer F; Blessberger H; Azar D; Goliasch G; Wagner O; Gerhold L; Huber K; Widhalm K; Abdolvahab F; Sodeck G; Maurer G; Schillinger M
Eur Heart J; 2009 May; 30(9):1073-9. PubMed ID: 19276196
[TBL] [Abstract][Full Text] [Related]
35. Clinical inquiries. When should we screen children for hyperlipidemia?
Misicko NE; St Anna L; Foliaco W
J Fam Pract; 2006 Aug; 55(8):723-5. PubMed ID: 16882449
[TBL] [Abstract][Full Text] [Related]
36. Familial combined hyperlipoproteinemia: experts panel position on diagnostic criteria for clinical practice. Committee of experts of the Atherosclerosis and Dysmetabolic Disorders Study Group.
Gaddi A; Galetti C; Pauciullo P; Arca M
Nutr Metab Cardiovasc Dis; 1999 Dec; 9(6):304-11. PubMed ID: 10765523
[TBL] [Abstract][Full Text] [Related]
37. Atorvastatin monotherapy vs. combination therapy in the management of patients with combined hyperlipidemia.
Avisar I; Brook JG; Wolfovitz E
Eur J Intern Med; 2008 May; 19(3):203-8. PubMed ID: 18395165
[TBL] [Abstract][Full Text] [Related]
38. Lack of agreement between the plasma lipid-based criteria and apoprotein B for the diagnosis of familial combined hyperlipidemia in members of familial combined hyperlipidemia kindreds.
del Rincon Jarero JP; Aguilar-Salinas CA; Guillén-Pineda LE; Gómez-Pérez FJ; Rull JA
Metabolism; 2002 Feb; 51(2):218-24. PubMed ID: 11833052
[TBL] [Abstract][Full Text] [Related]
39. Ezetimibe treatment of pediatric patients with hypercholesterolemia.
Clauss S; Wai KM; Kavey RE; Kuehl K
J Pediatr; 2009 Jun; 154(6):869-72. PubMed ID: 19230898
[TBL] [Abstract][Full Text] [Related]
40. Can we exclude the TXNIP gene as a candidate gene for familial combined hyperlipidemia?
van der Vleuten GM; Hijmans A; Heil S; Blom HJ; Stalenhoef AF; de Graaf J
Am J Med Genet A; 2006 May; 140(9):1010-2. PubMed ID: 16575890
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
